BIM
CHTP

BlackRock Investment Management’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

BlackRock Investment Management’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-217,747
Closed -$1.2M – 4143
2014
Q1 		$1.2M Buy
217,747
+4,738
+2% +$23.8K ﹤0.01% 2381
2013
Q4 		$945K Buy
213,009
+21,731
+11% +$73.4K ﹤0.01% 2548
2013
Q3 		$572K Buy
191,278
+16,626
+10% +$47.8K ﹤0.01% 2841
2013
Q2 		$402K Buy
+174,652
New +$353K ﹤0.01% 2964

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BlackRock Investment Management's CHTP Position: Q2 2014 in Review

BlackRock Investment Management sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 217,747 shares — an estimated $1.2M sold.

BlackRock Investment Management first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $1.2M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • BlackRock Investment Management reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • BlackRock Investment Management sold 217,747 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $1.2M.
  • BlackRock Investment Management first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • BlackRock Investment Management's CHELSEA THERAPEUTICS INT'L LTD position peaked at $1.2M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on BlackRock Investment Management's 13F filing for Q2 2014, filed 6 Aug 2014.